Abraaj’s Cleopatra Hospital prices offering at EGP 9.00 per share, first day of trading one week from today: Cleopatra has set the price for its offer of 40 mn existing ordinary shares (or about 25% of the company’s outstanding share capital) at EGP 9.00 per share, according to the company’s price announcement. The offering includes 34 mn shares to institutional investors in an international offering, which was was 6.73x oversubscribed, having generated EGP 2.1 bn (c. USD 231.9 mn) in demand. Another 6 mn shares will be put up in an Egyptian retail offering, the price announcement for which appears in the domestic press this morning. The company had previously given an indicative price range for the offering of EGP 8.75-11.88 per share. Selling shareholders will reinject the proceeds of the transaction into Cleopatra to drive new growth, including the development of extensions of Al Shorouk Hospital and Cleopatra Hospital and the potential acquisition of a site in New Cairo to develop into a new hospital, said Cleopatra Hospital Company’s chairman and CEO Dr. Ahmed Ezzeldin. Trading in the shares on the EGX is expected to commence on Thursday, 2 June under the ticker CLHO.CA. EFG Hermes is the sole global coordinator and bookrunner for the offering. Freshfields Bruckhaus Deringer LLP is international counsel to Cleopatra Hospital Company, while Zulficar & Partners are local counsel. Shearman & Sterling (London) LLP is international counsel to the sole global coordinator and bookrunner, while Matouk Bassiouny is local counsel.